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APACHE = Acute Physiology and Chronic Health Evaluation; ASA = American Society of Anesthesiologists; ICU = intensive care unit; POSSUM =
Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity.
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Abstract
The definition of risk in surgical patients is a complex and
controversial area. Generally risk is poorly understood and
depends on past individual and professional perception, and
societal norms. In medical use the situation is further complicated
by practical considerations of the ease with which risk can be
measured; and this seems to have driven much risk assessment
work, with a focus on objective measurements of cardiac function.
The usefulness of risk assessment and the definition of risk is
however in doubt because there are very few studies that have
materially altered patient outcome based on information gained by
risk assessment. This paper discusses these issues, highlights
areas where more research could usefully be performed, and by
defining limits for high surgical risk, suggests a practical approach
to the assessment of risk using risk assessment tools.
Introduction
What is a high-risk patient? What do we mean by risk? Why
do we want to assess risk? How do we want to use this
analysis? As intensivists we use risk assessment to identify a
highly selected group of patients who are at such high risk of
morbidity and mortality that they might benefit from high-
dependency unit or intensive care unit (ICU) care
perioperatively, and we seek to identify those patients who
might benefit from haemodynamic manipulation to improve
these outcomes. The intensivist’s perception of risk and aims
of risk assessment may well differ from that of the patient,
carers and other doctors, leading to communication
difficulties. The present paper explores risk, the need for risk
assessment, perception of risk, and various methods for
assessing risk. We also explore some of the problems and
misconceptions about risk assessment.
The perception of risk
As a society we do not think rationally about risk. Our ability
to risk assess is poor and we seem to be driven by fear and
hope as much as by rational evidence. The terms applied to
risk are also confusing; it is unlikely that many decision-
makers can differentiate the information available from
‘relative risk’, ‘absolute risk’ and ‘number needed to treat’ (see
Table 1). There is also little to suggest that the knowledge of
risk influences public response — recent examples include the
scare over ‘mad cow disease’ and the MMR vaccine [1] —
and there is little research available as to how knowledge of
patient risk modifies our behaviour as doctors. Furthermore,
there is little evidence of any reduction in morbidity or
mortality following the institution offering a risk assessment
protocol in the clinical setting [2]. The poor uptake of risk
identification strategies and optimisation protocols may be as
much to do with our blunted cultural perception of risk as
with resource limitations. The patient, their family, the
surgeon, the anaesthetist, the intensivist and the hospital
administrator are all likely to perceive risk in entirely different
ways while labouring under the misapprehension of a
common dialogue.
In the context of patient treatment when discussing risk the
perspective of the individuals involved will not only receive the
risks differently, but will also prioritise and compare the risks
in a different way (Table 2). Furthermore, there is confusion
between risks when used as a screening tool: it is, for
example, probable that most individuals with a poor outcome
will not manifest the risk factor, and conversely some
individuals with a good outcome will have the risk [3]. The
discussion of risk can therefore be fraught with difficulty and
in many cases is open to misinterpretation and profound
misunderstandings.
Why is risk assessed?
The reason for risk assessment depends on who is making
the assessment. Risk assessment is performed both for the
individual patient and for a patient cohort. A doctor may
assess the individual patient’s risk in order to better inform
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the patient and to allow consensual decisions for procedures
to be undertaken. Risk assessment might allow consideration
of a change in plan to reduce that individual’s risk; for
example, a more limited operation, modification of the
planned anaesthetic technique or perioperative haemo-
dynamic optimisation. In a more complex format, risk is
assessed to allow suitable targeting of therapeutic options
and decision-making with regard to treatment choices so that
a suitable balance of risks, often between the possible side
effects and dangers of surgery and the potential success of
treatment, can be made. Implicit in risk assessment for the
individual is the intention of subsequent action to achieve risk
reduction, but as already noted this is often not achievable.
At an institutional level the assessment of risk for a group of
patients can be used to target resources, both financially and
in terms of personnel and facilities. In this context, risk
assessment is no longer targeted towards the individual
patient. Similarly, risk assessment can be used as part of a
standardisation tool to allow comparison of outcomes
between different surgeons or hospitals who are undertaking
similar procedures. Risk assessment tools need to be able to
account for differences in populations such that one
hospital’s cohort of patients might be more frail at the outset.
What is a high-risk surgical patient?
In the context of critical care ‘high risk’ is used to donate the
global risk of mortality or morbidity, particularly with regard to
organ failure, compared with other groups at lower risk. As
regards surgical patients, information provided by the
National Confidential Enquiry into Peri-Operative Deaths
helps to address the issue of where a baseline for risk might
lie [4]. There are between 2.8 million and 3.3 million
operations per year in England, Wales and Northern Ireland.
The risk of death within 30 days of any operation has been
estimated as between 0.7% and 1.7%. The National
Confidential Enquiry into Peri-Operative Deaths also provides
information that we are not good at estimating surgical risk;
surgeons perceived that was increased risk in only 66% of
the patients that actually died, which equally means that an
increased risk was not identified in 44% of these patients.
From a practical point of view ‘high risk’ can probably be
defined in two different ways: the first is relevant to an
individual and suggests that the risk to an individual is higher
than for a population; the second compares the risk of the
procedure in question with the risk of surgical procedures as
a whole. In the first scenario it would be tempting to state that
risk is ‘high’ if the risk for an individual falls above two
standard deviations of the risk for the entire population
undergoing that type of surgery. This could be described as a
statistical approach but we suggest that this is only rarely
applicable due to lack of knowledge of baseline risk and also
to general misunderstandings of this type of statistical
analysis. We suggest that a far more understandable
description of high risk would be if the individual’s risk of
mortality is either >5% or twice the risk of the population
undergoing that procedure. The second description also
addresses the second scenario, and we suggest that a high-
risk procedure is one with mortality greater than 5%.
Furthermore, we would suggest that surgical patients for
whom the probable mortality is greater than 20% should be
Table 1
Different ways to describe ‘risk’
Placebo arm (n = 1000) Treatment arm (n = 1000) Relative risk reduction Absolute risk reduction Number needed to treat
200 100 50 10 10
20 10 50 1 100
2 1 50 0.1 1000
In this example, a treatment trial involving 2000 patients, ‘relative risk reduction’ remains the same while ‘absolute risk reduction’ and ‘number
needed to treat’ show differences in the appreciation of risk as the success of the treatment is modelled to change.
Table 2
Important milestones in the perception of high risk
Patient Ability to return to work
Possibility of disability
Success of operation
Family Will patient be able to resume role as carer?
Will patient survive?
Nurse Infection transmission
Violence towards self
Surgeon Likelihood of operative success
Possibility of operative misadventure
Anaesthetist Likelihood of surviving 30 days
Likelihood of surviving the anaesthetic
Intensivist Likelihood of leaving the intensive care unit
Prolonged stay on the intensive care unit
Administrator Outcome poorer than comparative unit
Care costing more than allocated392
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considered ‘extremely high-risk’ patients. Studies show that
mortality for this cohort can be improved by haemodynamic
optimisation and their care should ideally be discussed with
ICU preoperatively. We understand that, at least in the United
Kingdom, there are limited ICU resources available for this
but we should recognise that there is evidence that pre-
emptive strategies could reduce the mortality for this group.
There is conflicting evidence that intraoperative haemo-
dynamic optimisation may modify the outcome for surgical
patients with a predicted mortality less than 20%. An
improved outcome for this cohort may be seen in reduced
hospital bed-days rather than a reduction in mortality, but due
to the number of surgical patients even modest reductions in
length of stay would have huge resource benefits.
We have made some suggestions of general limits for
defining ‘high risk’. We fully understand, however, that how
‘high risk’ is actually defined is influenced by all the personal
perceptions and expectations already mentioned, as well as
the more pragmatic possibilities of influencing change and
costs. It is also interesting to compare the presented
definitions with the various studies of ‘high risk’ surgical
patients where different levels of risk have been thought to be
appropriate (Table 3).
Risk assessment in surgical patients
There are a number of tests that can be used to preoperatively
stratify risk in surgical patients. These can be divided into
general tests and scores, and those specific for myocardial
problems; specifically, postoperative myocardial infarction and
sudden cardiac death. There are various risk assessment
scores that aim to identify other morbidity-specific outcomes,
such as respiratory failure, wound infection or sepsis, but we
have limited ourselves to mortality and cardiac outcomes as
these constitute the best known scores and tend to be
applicable to wider groups of operative procedures.
General preoperative risk stratification
There are a number of methods by which risk can be
assessed preoperatively. These can be related to the type of
surgery and the known risks and outcomes of the planned
procedures, or they can be related to factors within the
patient themselves. Risk factors related to the surgery include
the surgical procedure and whether that procedure is
undertaken in an elective fashion or as an emergency. A
number of databases have demonstrated the higher risk
associated with emergency procedures. Risk factors related
to the patient can be relatively simple to isolate, such as the
patient’s age, or can take into account various methods for
assessing comorbidity or physiological reserve. The simplest
and most widely used method for assessing the comorbidity
is the American Society of Anesthesiologists (ASA) grading
on a scale of I to IV; this combined with the type of urgency of
surgery has been shown to be related to postoperative
mortality [5]. Other pragmatic assessments of preoperative
comorbidity have been employed by various investigators
attempting to identify patients at higher risk of morbidity and
mortality following surgery. One method, originally described
by Shoemaker and colleagues [6] and adapted by Boyd and
colleagues [7], identifies patients by the pre-selected list of
criteria presented in Table 4. While these types of
preoperative assessment clearly identify patients at much
higher risk than those in the general population of patients
undergoing surgery, they are open to some subjective
interpretation that makes them less robust to use if they are
carried outside the original institution.
The ASA classification of physical status was originally
introduced in 1941 as a tool for statistical analysis [8]. It was
modified in 1963 when the number of grades was reduced
from seven to five [9]. More recently an additional suffix ‘E’ for
emergency operation has been added. A high ASA score is
predictive of both increased postoperative complications and
mortality after non-cardiac surgery. The ASA classification
has relatively robustly stood the test of time, probably
Table 3
Control group mortality in four well-known studies that have
investigated ‘high-risk’ surgical patients
Study Mortality (%)
Shoemaker and colleagues [6] 33
Boyd and colleagues [57] 22.2
Wilson and colleagues [58] 17
Sandham and colleagues [59] 7.7
Table 4
Clinical criteria for high-risk surgical patients used by
Shoemaker and colleagues [6] and adapted by Boyd and
colleagues [7]
Previous severe cardiorespiratory illness — acute myocardial infarction,
chronic obstructive pulmonary disease, or stroke
Late-stage vascular disease involving aorta
Age >70 years with limited physiological reserve in one or more vital
organs
Extensive surgery for carcinoma (e.g. oesophagectomy, gastrectomy
cystectomy)
Acute abdominal catastrophe with haemodynamic instability 
(e.g. peritonitis, perforated viscus, pancreatitis)
Acute massive blood loss >8 units
Septicaemia
Positive blood culture or septic focus
Respiratory failure: PaO2 <8.0 kPa on FIO2 >0.4 or mechanical
ventilation >48 hours
Acute renal failure: urea >20 mmol/l or creatinine >260 mmol/l393
because it is simple to calculate without requiring additional
resources. It may be surprising that it is predictive, as ASA
scoring does not take into account age, weight or the nature
of the intended operation. Studies show that there may be
significant interoperator variability in ASA scoring. Other
more complex scoring systems have greater prognostic
accuracy but ASA scoring remains useful [10]. It has began
to be used outside operating theatres, such as in helping to
assess patients fitness for endoscopy, and it is a useful tool
to help non-anaesthetists to consider potential procedural-
related risks (see Table 5).
A slightly different approach has been taken by Older and
colleagues, who have performed preoperative cardio-
pulmonary testing to define an anaerobic threshold in patients
in the preoperative period [11,12]. In an initial study of 187
patients, there were 55 patients in whom the anaerobic
threshold was <11 ml/min/kg; of these, 10 patients died (a
mortality rate of 18%). There were 132 patients with an
anaerobic threshold >11 ml/min/kg, and of these one patient
died (mortality rate of 0.8%). If a low anaerobic threshold was
associated with preoperative ischaemia on the electro-
cardiogram the results were much worse, with eight of 19
patients dying (giving a mortality rate of 42%). When the
ischaemia was associated with the higher anaerobic
threshold, one patient out of 25 died (a mortality rate of 4%)
[11]. This work has been taken further, by describing different
treatment paths for the high and low anaerobic threshold
groups, and although this is not a randomised trial the results
appear to show that greater degrees of intervention in the low
anaerobic threshold group reduce mortality [12].
Many of these methods used for assessing risk in the
preoperative period are labour intensive and require
expensive and specialised equipment; this is particularly so
for the assessment of anaerobic threshold. While these
efforts may be good at assessing risk, there is a paucity of
clinical studies showing how this has changed the
management of either individual patients or groups of
patients. We hope that soon data will appear showing how
preoperative risk assessments have changed individual
patient management; for example, how surgical anaesthetic
perioperative practice has changed for an individual patient.
While this would be a good start and would allow decision-
makers to place the techniques for assessing preoperative
risk in a decision-making context, we still really require studies
to show how preoperative assessments have changed
outcomes as part of a clinical trial. The only literature with
which we are familiar in this context comes from the work
concerning goal-directed therapy, which shows that when
risk is assessed based on very simple preoperative scores,
and when treatment is targeted to various goals of
cardiorespiratory function, both mortality and morbidity are
reduced [13].
Preoperative risk stratification for myocardial events
Two cardiac risk indices are well known. The first is the
Goldman Index [14], which represents a practical and
inexpensive method for identifying cardiac risk [15], but over
time may need to be modified to represent the true mortality
rate [16]. A second score was developed by Detsky and
colleagues [17], and both this score and the Goldman Index
are good predictors of perioperative cardiac events with odds
ratios of 0.642 (95% confidence interval, 0.588–0.695) for
the Goldman index and of 0.601 (95% confidence interval,
0.544–0.657) for the modified Detsky index [18]. Other
factors such as comorbidity and intraoperative factors
influence outcome, however, and no preoperative system will
be completely accurate [19,20].
There are many methods to investigate cardiac function and
coronary artery perfusion, and it is hardly surprising that many
have been investigated for their ability to stratify risk in
surgical patients undergoing non-cardiac surgery [21,22]. It
is disappointing that while many of these can clearly identify
different risks, there is very little information that outcome is
improved by knowing the risk [23–25].
A recent study has confirmed that exercise stress testing can
be a useful method of risk stratification. Gauss and
colleagues shown that an ST-segment depression of 0.1 mV
or more in the exercise electrocardiogram had an odds ratio
Available online http://ccforum.com/content/9/4/390
Table 5
American Society of Anaesiologists’ status classification: modified from Wolters and colleagues [10]
Class Description Mortality (%)
I Healthy 0.1
II Mild systemic disease — no functional limitation 0.7
III Severe systemic disease — definite functional limitation 3.5
IV Severe systemic disease — constant threat to life 18.3
V Moribund patient unlikely to survive 24 hours with or without operation 93.3
E Emergency operation394
of 5.2 (95% confidence interval, 1.5–18.5; P = 0.01) of
predicting a myocardial infarction or postoperative myocardial
cell injury in non-cardiac surgery patients [26]. A combination
of clinical variables and exercise electrocardiography
improved preoperative risk stratification.
Other studies have used echocardiography [27] and stress
echocardiography to risk-stratify surgical patients. But adding
echocardiographic information to established predictive
models may not alter the sensitivity, specificity or predictive
values in a clinically important way [28]. Dobutamine stress
echocardiography resulting in hypotension [29], ischaemia
[30] or wall motion abnormalities [31,32] can have predictive
value for postoperative cardiac events [33–37]. Dipyridamole
echocardiography has also been used with good predictive
results [38,39]. Furthermore, echocardiography without
pharmacological stress can also be a useful screening test
[40], and can be used during surgery and can give useful
information on cardiac status [41,42].
As has already been discussed there is a paucity of clinical
information describing how any of these preoperative risk
assessments has either influenced the management of
individual patients or of patient groups in the context of a
clinical study. One notable exception is a study by
Poldermans and colleagues [43]. Patients undergoing major
vascular surgery were identified as being of particularly high
risk by dobutamine echocardiography and were then
randomised to receive perioperative care or standard care
plus perioperative β-blockade with bisoprolol. A total of
1351 patients were screened and 112 patients suitable for
randomisation were identified. Study results showed that
mortality from cardiac causes was significantly reduced in
the bisoprolol group [43]. The lack of further clinical data,
however, has not prevented professional and learned groups
from producing written guidelines for patient management.
The American College of Cardiology published guidelines in
1996 on the preoperative assessment of patients having
non-cardiac surgery and gave specific indications for the use
of blockade in these patients [44]. Although the most
recently published version of these guidelines is less
didactic [45], they still show how consensus opinion can
influence clinical management even though the evidence
base is so poor.
Postoperative risk stratification
In the global context of critical care medicine there is a
number of scoring systems in general use. Many of these
systems are used for severity of illness scoring so that
standardised comparisons can be made between patient
groups and between ICUs; however, to some extent they can
be used to assess risk for patient groups if not for individual
patients. Severity of illness scoring systems such as Sepsis-
related Organ Failure Assessment and Therapeutic
intervention scoring system are widely known, but perhaps
the most widely used scoring system is the Acute Physiology
and Chronic Health Evaluation (APACHE) scoring system
[46]. The APACHE system includes chronic health data
concerning the individual patient and physiological data
collected during the patients first 24 hours of intensive care
treatment. The APACHE system, in common with other
general scoring systems, can only be used after an operation,
and therefore any risk assessment ability within these scores
can only be applied post hoc to groups of patients. In the
APACHE system, risk comparisons are frequently undertaken
by comparing standardised mortality ratios, and there is some
doubt about the standardised mortality ratio to robustly allow
comparisons to be made [47].
The scoring system that has been specifically designed for
surgical patients is the Physiological and Operative Severity
Score for the enUmeration of Mortality and morbidity
(POSSUM) score [48]. This is generally accepted to be a
good scoring system for routine use [49], and is better than
the APACHE system for a general surgical group of patients
[50]. But in specific situations such as ruptured abdominal
aortic aneurysms POSSUM scoring is not a good predictor of
outcome and APACHE scoring is better [51]. POSSUM
scoring was also inaccurate in laparoscopic colectomy [52].
Variations of POSSUM scoring have been suggested that
may work better in gastrointestinal surgery [53], specifically in
oesophageal surgery [54] and vascular surgery [55].
Furthermore, in one study POSSUM scoring has been used
as part of a risk stratification analysis to identify patients who
might benefit from postsurgical high-dependency care or ICU
care [56].
Conclusion
Risk is a term that is understood differently by different
individuals depending on expectation and previous
experience. There are methods that can be used to assess
risk in various patient groups, but these provide population
risks and are not directly applicable to individual patients.
Frequently the cut off between those patients assessed as
being at high risk and those at lower risk depends on the cost
and complexity of providing treatment to correct the risk,
rather than on the risk itself. It remains extremely
disappointing that there is little evidence that any change in
patient outcome has been driven by the pre-existing
knowledge of risk for that patient. In the future, risk
assessment in medical practice, particularly in intensive care
medicine where risks of the ultimate negative outcome are so
high, will only be advanced by the following: an inclusive
debate involving patients, medical staff and other religious,
ethical and cultural groups to understand the nature of
medical risk and to form priorities in its assessment and
management; the development of more accurate methods to
assess and predict risk prior to the onset of an index event,
which can be directed towards identifying risk for the
individual; and the conduct of clinical trials to show that prior
knowledge of individual risk can allow treatment and
management decisions to be adapted to treat different
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patients in different ways with a benefit in patient outcome,
however that is to be defined.
In our opinion the two most useful scoring systems in surgical
risk assessment remain the ASA score and the clinical criteria
as used by Shoemaker/Boyd and colleagues. Both of these
assessments are simple to use and do not require additional
resources. The purpose of an effective scoring system is to
highlight potential high-risk patients for busy hospital practi-
tioners and to act as a focus for generating a multidisciplinary
risk/benefit discussion between interested parties.
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